FR2200016B1 - - Google Patents

Info

Publication number
FR2200016B1
FR2200016B1 FR7334541A FR7334541A FR2200016B1 FR 2200016 B1 FR2200016 B1 FR 2200016B1 FR 7334541 A FR7334541 A FR 7334541A FR 7334541 A FR7334541 A FR 7334541A FR 2200016 B1 FR2200016 B1 FR 2200016B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7334541A
Other versions
FR2200016A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP9649772A external-priority patent/JPS5647899B2/ja
Priority claimed from JP9649972A external-priority patent/JPS4951275A/ja
Priority claimed from JP9649872A external-priority patent/JPS4951268A/ja
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of FR2200016A1 publication Critical patent/FR2200016A1/fr
Application granted granted Critical
Publication of FR2200016B1 publication Critical patent/FR2200016B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7334541A 1972-09-26 1973-09-26 Expired FR2200016B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP9649772A JPS5647899B2 (fr) 1972-09-26 1972-09-26
JP9649972A JPS4951275A (fr) 1972-09-26 1972-09-26
JP9649872A JPS4951268A (fr) 1972-09-26 1972-09-26

Publications (2)

Publication Number Publication Date
FR2200016A1 FR2200016A1 (fr) 1974-04-19
FR2200016B1 true FR2200016B1 (fr) 1976-10-22

Family

ID=27308116

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7334541A Expired FR2200016B1 (fr) 1972-09-26 1973-09-26

Country Status (5)

Country Link
US (1) US3880825A (fr)
CA (1) CA1009230A (fr)
DE (1) DE2348221C3 (fr)
FR (1) FR2200016B1 (fr)
GB (1) GB1422276A (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4083967A (en) * 1973-11-01 1978-04-11 Burroughs Wellcome Co. Nona- and decapeptides
US3992365A (en) * 1973-11-01 1976-11-16 Burroughs Wellcome Co. Agonist analogues of luteinizing hormone releasing hormone
US4261887A (en) * 1973-11-06 1981-04-14 The Salk Institute For Biological Studies Peptide compositions
NL7505590A (nl) * 1974-05-18 1975-11-20 Hoechst Ag Werkwijze voor het bereiden van peptiden met lh-rh/fsh-rh-werking.
GB1532211A (en) * 1974-10-25 1978-11-15 Wellcome Found Lh-rh peptide analogues
US4034082A (en) * 1976-03-01 1977-07-05 Abbott Laboratories Method to prevent reproduction in warm-blooded female animals with nonapeptides
US4093611A (en) * 1977-04-07 1978-06-06 Parke, David & Company Octapeptides and methods for their production
US4101537A (en) * 1977-04-07 1978-07-18 Parke, Davis & Company Octapeptides and methods for their production
US5389613A (en) * 1979-09-21 1995-02-14 Roussel Uclaf Method of treating prostate adenocarcinoma, prostate benign hypertrophia and endometriosis
FR2465486A1 (fr) * 1979-09-21 1981-03-27 Roussel Uclaf Nouvelle application utilisant la lh-rh ou des agonistes
GB2089209B (en) * 1980-06-26 1984-09-05 Salk Inst For Biological Studi Contraceptive treatment of male mammals
US5068221A (en) * 1989-05-09 1991-11-26 Mathias John R Treatment of motility disorders with a gnrh analog
US5434136A (en) * 1990-12-14 1995-07-18 Mathias; John R. Treatment of motility disorders with a GNRH analog
US5763577A (en) * 1993-10-25 1998-06-09 Warner-Lambert Company Substituted tetra- and pentapeptide inhibitors of protein: farnesyl transferase

Also Published As

Publication number Publication date
GB1422276A (en) 1976-01-21
DE2348221C3 (de) 1976-03-25
CA1009230A (en) 1977-04-26
DE2348221B2 (de) 1975-08-07
US3880825A (en) 1975-04-29
DE2348221A1 (de) 1974-04-18
FR2200016A1 (fr) 1974-04-19

Similar Documents

Publication Publication Date Title
BE788499A (fr)
BG18292A1 (fr)
BG18373A1 (fr)
BG18386A1 (fr)
BG19428A1 (fr)
CH1486873A4 (fr)
CH1626173A4 (fr)
CH1668773A4 (fr)
CH322372A4 (fr)
CH545715A (fr)
CH545741A (fr)
CH546010A (fr)
CH555674A4 (fr)
CH561428A5 (fr)
CH561453A5 (fr)
CH564321A5 (fr)
CH564392A5 (fr)
CH564448A5 (fr)
CH567798A5 (fr)
CH569076A5 (fr)
CH570064A5 (fr)
CH570503A5 (fr)
CH571764A5 (fr)
CH572363A5 (fr)
CH572410A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse